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1. Introduction 
Ring-enhancing intracranial lesions constitute a common and quite puzzling diagnostic 
dilemma. These lesions may present as solitary or multiple on a routine brain MRI, and are 
characterized by a contrast enhancing halo and a non enhancing center. The central part 
may present with low signal intensity on T1, and high signal intensity on T2 weighted 
images. They are usually surrounded by a variable amount of edema. They may be located 
anywhere in the brain, although the junctional zone of gray-white matter is their most 
common location [Omuroet al., 2006; Smirniotopoulos et al., 2007]. Their size may vary from 
a few millimetres to several centimetres.   
The differential diagnosis of ring enhancing lesions is quite large. It may include neoplasms, 
infections, inflammatory processes, or vascular pathologies. The incidence of each 
pathological entity depends highly on the geographical region and the study population. It 
is well documented that infections and inflammatory processes are more common in 
developing countries, while neoplasms and demyelinating lesions are more frequent in 
developed countries. Clinical history is not always helpful in their differential diagnosis, 
since more than 50% of CNS infections may present without fever and no obvious inflicting 
incident. Moreover, other laboratory tests may not be able to help in their differential 
diagnosis. In addition, the presenting symptomatology and the clinical examination of these 
patients are non-specific and frequently overlapping, making thus the establishment of an 
accurate diagnosis quite difficult. 
Routine brain MR imaging is very sensitive in the identification of ring enhancing lesions 
but it cannot distinguish between neoplastic and non neoplastic lesions, in a large 
percentage of these cases. Frequently, the differentiation of a tumor from an infection is 
quite difficult, based solely on conventional MRI. Therefore, advanced MR imaging 
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techniques as Diffusion Weighted Imaging (DWI), Perfusion Weighted Imaging (PWI), and 
proton Magnetic Resonance Spectroscopy (1HMRS) have been employed in the differential 
diagnosis of these lesions, with variable success rates. These studies are employed in 
combination with conventional MRI as complimentary imaging tests, and may significantly 
increase its specificity. 
In this chapter, the role of 1HMRS in the differential diagnosis of ring enhancing lesions is 
going to be discussed. The basic principles of 1HMRS, as well as, the typical spectroscopic 
profiles of the most commonly encountered ring enhancing lesions, are also presented. 
Furthermore, the implementation of other MR advanced techniques as DWI and PWI 
along with 1HMRS in the evaluation of patients harbouring ring enhancing lesions, are 
analyzed.  
2. Basic principles of 
1
HMRS 
Proton MR Spectroscopy (1HMRS) is a noninvasive imaging technique that may contribute in 
the preoperative diagnosis of patients with MR ring enhancing lesions. 1HMRS depends on a 
change in the resonance frequency of the nuclei within the molecules, regarding their chemical 
bonds, which is based on the chemical shift theory. The resonance frequency difference 
(chemical shift) is expressed as parts per million or ppm, a value that is independent of the 
amplitude of the external magnetic field. The value of the chemical shift provides information 
about the molecular group carrying the hydrogen nuclei, and thus it provides differentiation 
among several metabolites. Water peak is located at 4,7 ppm, and is much greater than the 
obtained signal from other hydrogen containing compounds typically identified in the brain 
parenchyma. Therefore, water signal needs to be suppressed for identifying any other 
metabolites. The reference frequency used, set at zero ppm, is that of tetra-methyl silane 
molecule Si-(CH3)4, which is symmetrical and has a single proton resonance.  
In order to perform in vivo 1HMRS, a strong magnetic field of at least 1.5T is required. It is 
generally accepted that, the higher the magnetic field strength, the more metabolites can 
be identified. Specific sequences for spectroscopic signal acquisition are either Single 
Voxel Spectroscopy (SVS), which receives the spectrum from a single voxel only, or 
Chemical Shift Imaging (CSI), which measures spectra in projection, on a slice (2D CSI), or 
a volume (3D CSI).  
3. Normal brain metabolites  
Proton MRS obtains information about brain tissue metabolism, which cannot be performed 
by conventional MRI scans [Wilson et al., 2009]. The principal metabolites, which are most 
commonly identified and evaluated in brain 1HMRS, and their characteristic frequencies and 
concentrations, are summarised in table 1. 
At a first glance, a normal brain spectrum contains five to ten resonance peaks (figure 1). N-
Acetyl-Aspartate (NAA) is considered to be a unique neuronal marker, reflecting the number 
of intact neurons in the gray matter, and the density of intact axons in the white matter 
[Majos et al., 2004]. In general, reduction of NAA is produced by benign and malignant 
lesions in various proportions, and is indicative of normal neuronal tissue destruction. More 
specifically, NAA concentration decreases may occur with neuronal dysfunction caused by 
ischemia, trauma, inflammation, infection, tumor, neurodegenerative processes or reactive 
gliosis. Therefore, NAA is considered to be a highly sensitive but not specific marker. 
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Choline (Cho) constitutes an essential compound of cellular membranes, and is considered to 
be a sensitive marker of cellular membrane metabolism [Miller et al., 1996]. Hence, variation 
in choline represents a wide range of abnormalities reflecting cell membrane destruction. 
Characteristically, tumors, inflammatory processes, demyelinating processes, and hypoxia 
show increased concentrations of Cho. Contrariwise, the concentration of Cho is decreased 
in cerebral abscesses.  
 
Metabolite  
Frequency (ppm) / 
Cerebral Concentration 
(mmol/kg) 
Physiological Role 
N-Acetyl-Aspartate(NAA) 
2.02 ppm /  
7.9-16.6 mmol/kg 
Neuronal cell marker.  
Choline (Cho) 
3.2 ppm /  
0.9-2.5 mmol/kg 
Marker of cell membrane 
metabolism. 
Creatine / Phosphocreatine 
(Cr) 
3.0 ppm /  
5.1-10.6 mmol/kg 
Compounds related to energy 
metabolism. 
Alanine(Ala) 
1.5 ppm /  
0.2-1.4 mmol/kg 
Is characteristic of meningeal 
tumors 
Lipids (Lip) 
0.9, 1.4 ppm /  
>1.0 mmol/kg 
Membrane breakdown product. 
Lactate (Lac) 
1.33 ppm /  
0.4 mmol/kg 
A product of anaerobic 
glycolysis. 
Myo-inositol 
(mI) 
3.6 ppm /  
3.8-8.1 mmol/kg 
Glial Marker 
Glutamate-Glutamine 
(“Glx”) 
γ-amino-butyric acid 
(“GABA”) 
2.1-2.4 ppm /  
1.3-12.6 mmol/kg 
Intracellular Neurotransmitter 
Markers 
Acetate 1.9 ppm Characteristic in abscess 
Succinate / Pyruvate 2.4 ppm Characteristic in abscess 
Table 1. Summary of the principal metabolites that are most commonly evaluated in 
Magnetic Resonance Spectroscopy (MRS) 
Total Creatine (Cr) is a composite peak from the methyl and methylene protons of Cr and 
phosphorylated creatine, (PCr). The concentration of total creatine was thought to be 
relatively constant in the brain. However, with the development of quantitative MRS 
analysis techniques, it has been demonstrated that the concentration of total Cr is not 
constant. It has been shown that Cr concentrations may vary among different brain regions 
and among various pathological entities, thus, the usage of Cr as a reference signal should 
be applied with extreme caution [Howe et al., 2003]. The concentration of Cr is reduced in 
tumors and hypoxia, while Cr is totally absent in cerebral abscesses.  
Lipids are normally absent from a normal brain MR spectrum, and their appearance 
represents necrosis. Increased concentrations of lipids may be observed in high grade 
primary and metastatic tumors, but also in abscesses and all necrotic lesions [Gotsis et al., 
1996]. 
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Fig. 1. Typical normal brain MR Spectrum showing the concentrations of Myoinositol (mI), 
Choline (Cho), Creatines (Cr), N-Acetyl-Aspartate (NAA),lipids (lip)and lactate (Lac) 
Lactate signal appears in the same region of proton MR spectrum as lipids, therefore, it may 
be difficult to be distinguished. Lactate represents a product of anaerobic glycolysis [Barker 
et al., 1994; Negendank et al., 1996]. Its concentration is increased in ischemia, but also in 
high grade gliomas, as well as in pyogenic abscesses. 
MyoInositol is a rather complex sugar alcohol, which gives rise to four groups of resonances. 
Its exact function is not completely known, although it has been proposed as a glial marker 
[Kallenberg et al., 2009]. Its concentration is reduced in high grade gliomas, but is also 
identified in meningiomas and demyelinating lesions.  
Alanine peak appears near, and is often overlapped, by the lipids peak. It represents a 
discriminating metabolite of tumors of meningeal origin [Shino et al., 1999], but it is also 
identified in pyogenic anaerobic abscesses and cysticercosis [Kapsalaki et al., 2008]. 
Aminoacids (acetate and succinate) are not identified in a normal brain spectrum. Their 
presence is characteristic of brain abscesses.  
In a routine clinical spectroscopic study, analysis of the obtained spectrum consists of 
measurement of the absolute concentrations of the identified metabolites, and calculation of 
the concentration ratios of the abovementioned metabolites. The most commonly used ratios 
include NAA/Cr, Cho/Cr, and NAA/Cho. Analysis of the accumulated data provides a 
characteristic metabolic profile, assigned to specific pathological entities. 
4. Technical limitations of 
1
HMRS   
The clinical use of proton MR spectroscopy presents several technical limitations and pitfalls 
[Castillo et al., 1996; Fountas et al., 2000; Preul et al., 1996; Rand et al., 1999; Shukla-Dave et 
al., 2001]. Proton MRS lasts approximately 15 min and requires the patient's cooperation for 
avoiding motion artifacts.  In single voxel MRS, the obtained region of interest should be 
appropriately placed at the center of the studied lesion, to avoid signal contamination from 
the surrounding tissues [Kimura et al., 2001]. It has been reported that even the slightest 
malpositioning of the voxel may result in up to 50% signal contamination of the obtained 
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spectrum, which may result in misinterpretation of the obtained spectroscopic study and 
subsequent imaging misdiagnosis. Moreover, calcifications, necrotic areas, and adjacent 
bony structures should be meticulously excluded from the obtained spectrum. Despite the 
recent advances in commercially available MRS software packages, the method remains 
operator dependent, and its accuracy is associated with the experience of the performing 
spectroscopist and the involved neuroradiologist. 
5. Characteristic MR Spectroscopic profiles of the most common ring 
enhancing lesions 
5.1 High grade astrocytomas  
Proton MRS provides information regarding the metabolic profile of a glioma indicating the 
concentrations of various metabolites in the lesion. The commonly identified spectrum of a 
high grade glioma in proton MRS presents reduced concentration of NAA, because of 
destruction of normal neurons, markedly elevated concentrations of Cho due to 
exponentially increasing cellular populations and increased cell membrane turnover, and 
decreased Cr due to a major shift in the utilized cellular metabolic pathways. In regard to 
the commonly calculated metabolic ratios, the higher the Cho/NAA ratio is, the higher the 
astrocytoma grade. Therefore, 1HMRS may suggest the area of highest malignancy within a 
non-homogenous glioma and accurately guide an open or stereotactic surgical biopsy. Lac 
appears infrequently in all grades of astrocytomas. Lipids are detected in high quantity in 
necrotic gliomas, in the area of the necrosis (figure 2). 
 
     
      (a)                                                                                    (b) 
Fig. 2. a: Proton MR Spectrum of a high grade tumor. DD includes glioblastoma and 
metastatic lesion. 2b: The presence of increased concentration of Cho in the surrounding 
brain edema is suggestive of an infiltrative lesion, as a glioma versus a metastatic lesion. 
It is well known that gliomas are highly infiltrating brain tumors, and their borders are 
typically ill-defined and cannot be accurately identified during their surgical removal 
[Croteau et al., 2001; Fountas et al., 2004; Mikkelsen & Edvardsen, 1995]. Performing MRS in 
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the surrounding edema may facilitate the identification of the glioma borders, and detect the 
presence and the extent of infiltration of a glioma. The identification of increased Cho and 
decreased NAA in the surrounding edema is indicative of infiltration, and is not 
characteristic of other ring enhancing lesions.  
5.2 Metastatic lesions  
The spectra of a ring enhancing metastasic tumor characteristically present very high 
concentrations of lipids, which are most probably associated with the presence of necrotic 
areas. Choline levels may also be elevated due to increased cell membrane destruction and 
turnover. However, the spectra of high grade gliomas and metastatic ring enhancing lesions 
are not easily distinguished [Burtscher et al., 2000; Opstad et al., 2004]. In such cases, spectra 
from the surrounding edema may provide additional important information. If normal 
concentrations of Cho and NAA are measured in a ring-enhancing lesion, this is more likely 
to be a metastatic lesion. Moreover, in metastatic lesions there is almost no Cr peak 
identified, which is not the case in high grade gliomas. (figure 3) 
 
  
        (a)                                                                                    (b) 
Fig. 3. a: The obtained spectrum demonstrates a very high peak representing severely 
increased concentration of lipids, which compresses all other metabolites, and suggests a 
highly necrotic lesion. Differential diagnosis between metastasis and glioma in this case is 
not possible. 3b: A normal spectrum of the surrounding brain edema suggests that the lesion 
is more compatible with a metastatic rather than an infiltrative tumor (glioma).  
5.3 Recurrent astrocytomas versus post-radiation necrosis  
Tumor recurrence and radiation-induced necrosis have similar MRI characteristics, and their 
distinction is usually difficult based solely on conventional MRI. Positron Emission 
Tomography (PET) has been suggested for differentiating between tumor recurrence and 
post-radiation necrosis [Kim et al., 2010; Tsuyuguchi et al., 2003] However, PET is a quite 
expensive imaging modality, with very limited distribution in clinical centers. Nevertheless, 
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1HMRS has a significant role in their differentiation, considering that in a recurrent glioma 
the presence of Cho with increased concentration is identified, and the Cho/Cr and 
Cho/NAA ratios are significantly increased, with absolute values higher than 1.76 
[Weybright et al., 2005; Schlemmer et al., 2002]. On the contrary, in cases of post-radiation 
necrosis, there is a marked reduction in the concentrations of all normally detected 
metabolites, along with a marked increase of lipids concentration. A study by Tarnawski and 
coworkers [Tarnawski et al., 2002] indicates that 1H-MRS has a clear prognostic value for 
predicting survival in gliomas, and provides a clear diagnosis of recurrence following 
radiation therapy. In the presence of inflammation, increased levels of Cho may be detected. In 
such cases, differentiation between radiation necrosis and tumor recurrence with 1HMRS alone 
is almost impossible. Other imaging modalities need to be combined, as perfusion MRI. 
5.4 Abscesses  
Cerebral abscesses contain no normal neurons and no membranous structures in their 
necrotic lesional center (Fountas et al., 2000; Lai et al., 2005). Therefore, no peaks of NAA, 
Cr, or Cho should be detected. A typical abscess spectrum shows the presence of cytosolic 
amino acids (leucine, isoleucine, and valine) [Garg et al, 2004; Kadota et al., 2001; Lai et al., 
2002; Remy et al.,1995; Tsui et al., 2002], which are the products of proteolysis caused by 
enzymes released from neutrophil cells. Because these metabolites have never been detected 
in neoplasms, their detection is strongly indicative of a cerebral abscess [Kapsalaki et al., 
2008]. Lactate is also detected in a large number of cerebral abscesses (figure 4).  
Proton MR spectroscopy may also contribute in the identification of the causative organism 
of an abscess [Lai et al. 2002]. Anaerobic microbial agents are characterized by the presence of 
lactate, cytosolic amino acids, alanine, acetate, succinate, and lipids. Aerobes and facultative 
anaerobes are characterized by the presence of lactate, cytosolic amino acids, and the 
occasional presence of lipids. Streptococcal abscesses are characterized by the presence of 
lactate, while Staphylococcal infections are associated with the presence of lipids and lactate 
 
 
Fig. 4. Characteristic MR spectrum of an abscess. Note the absence of Cho, Cr, and NAA and 
also the increased concentrations of various aminoacids (acetate, alanine, lactate).   
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[Himmelreich et al., 2005]. It is apparent that identification of the etiologic factor of an 
abscess contributes significantly in its prompt and timely treatment. Moreover, 1HMRS may 
contribute in the evaluation of the evolution and treatment response of a cerebral abscess. 
Sequential spectroscopic analysis of a brain abscesses may detect changes in the 
concentrations of the initially detected metabolites, providing thus a non-invasive 
methodology for evaluating the evolution of  a cerebral abscess, and also its response to the 
administered antibiotic treatment. 
5.5 Subacute infarct  
Markedly elevated lactate is the key spectroscopic feature of cerebral hypoxia and ischemia, 
because of a major metabolic shift to anaerobic glycolysis. Choline is also elevated, with 
variable concentrations, while NAA and Cr concentrations are reduced. If cerebral infarction 
ensues, concentration of lipids will also increase. Furthermore, additional MR based 
advanced imaging modalities, such as Diffusion and Perfusion Weighted Imaging, may 
significantly contribute in the differential diagnosis in these cases [Parsons et al., 2000]  
5.6 Demyelination 
Proton MRS is a very useful tool in evaluating solitary tumefactive multiple sclerosis (MS) 
lesions. In acute MS lesions inflammation is the initial pathological change, while in more 
chronic lesions demyelination occurs. Proton MRS may be a quite sensitive imaging 
modality for evaluating axonal damage. At the initial presentation of MS, a typical spectrum 
shows decreased concentration of NAA, increased Choline and myo-inositol (MI) 
concentrations, and elevated concentration of Lactate, due to inflammation. With 
progression of an MS plaque, 1HMRS shows normalization of MI and Lac levels, while Cho 
and NAA may remain unchanged. Thus, an MS spectrum may not be always diagnostic of a 
demyelinating lesion (figure 5). Taking into account the increased concentration of lactate at  
 
  
         (a)                                                                                  (b) 
Fig. 5. (a) Characteristic proton MR spectrum of an acute MS plaque. Note the presence of 
slightly increased Cho, decreased concentration of NAA, and slightly increased 
concentration of Lactate (b) Spectrum obtained from a cerebellar demyelinating lesion. This 
spectrum is not suggestive of demyelination and may be erroneously diagnosed as a 
spectrum suggestive of a low grade glioma.   
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the initial phase, this finding may contribute to the establishment of an accurate diagnosis. 
However, it has to be emphasized that in cases that a demyelinating process is suspected, 
completion of the diagnostic investigation with other imaging and laboratory studies is 
often necessary [De Stefano & Filippi, 2007; Rovira & Leon, 2008; Takenaka et al., 2011]. 
6. Contribution of Diffusion Weighted Imaging (DWI) and Perfusion Weighted 
Imaging (PWI) in the distinction of ring enhancing lesions 
6.1 Diffusion Weighted Imaging 
Diffusion-weighted imaging (DWI) is an MRI technique, which is based on the Brownian 
motion of molecules. Diffusion-weighted imaging detects the tracing of the microscopic 
motion of water molecules, thus reflecting the microstructure of local tissue. Free motion of 
water molecules in all directions is called isotropic diffusion, while motion of water 
molecules in a specific direction, like a myelinated axon, is called anisotropic diffusion. The 
diffusion data can be presented as signal intensity, or as an image map of the apparent 
diffusion coefficient (ADC). Calculation of the ADC requires two or more acquisitions with 
different diffusion weightings. Increased signal intensity on DWI corresponds to restricted 
diffusion and low ADC, while low signal intensity on diffusion-weighted images 
corresponds to normal diffusion and a high ADC.  
DWI is a method detecting the diffusion properties of water molecules, and is restricted in 
subacute ischemia, brain abscesses, and lymhomas. It is usually not restricted in cystic 
lesions. Application of DWI has been extensively described in the literature [Bükte et al., 
2005; Chang et al., 2002]. Cystic lesions and necrotic brain tumors, primary or metastatic, 
that have a “cystic” central area, show normal diffusion, since the cystic area is caused by 
liquefaction (necrosis) of the tumor, that permits free motion of the molecules. However, 
several studies report the presence of restricted diffusion in necrotic brain gliomas, making 
the use of other imaging modalities mandatory [Chang et al., 2002;  Holtas et al., 2000; Lai et 
al., 2007]. On the contrary, in brain abscesses the cystic part reflects the presence of 
inflammatory cells, debris and possibly bacteria, that restrict the free motion of the 
molecules, and thus cause restricted diffusion, which appears with increased signal 
intensity. However, diffusion may also be restricted in several cases of malignant brain 
tumors, in acute demyelinating lesions, and in acute encephalitis. In such cases, the 
employment of 1HMRS, along with DWI may contribute in the differentiation of these 
lesions.  
6.2 Perfusion Weighted Imaging  
Perfusion Weighted Imaging (PWI), is the dynamic contrast imaging of the passage of 
intravenously injected paramagnetic contrast agent. Perfusion Weighted Imaging requires 
the acquisition of fast T2* images. After bolus intravenous contrast administration, the T2* 
images show drop of signal intensity, and as time passes, data are obtained in the form of  
cerebral blood flow (CBF), cerebral blood volume (CBV), and mean transit time (MTT). A 
time-intensity curve is generated for each voxel in each MR slice. The time-to-peak (TTP) is 
the time from the start of the scan until the maximum contrast attenuation occurs. The mean 
transit time (MTT) is the time it takes the contrast bolus to pass from the arterial to the 
venous side of the cerebral circulation. The entire area under the curve is a measure of 
relative cerebral blood volume (rCBV). Moreover, a measure of relative cerebral blood flow 
(rCBF) is calculated by dividing the rCBV by the MTT. 
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Perfusion Weighted Imaging is important in the diagnosis of brain tumors and the 
differentiation of recurrent gliomas from post-radiation necrosis. Malignant high grade 
gliomas demonstrate neovascularization that is detected by PWI, showing a correlation 
between microvessel density and histological tumor grade. The higher the tumor grade is, 
the higher the rCBV will be (Sugahara et al., 1998; Provenzale et al., 2006). Perfusion 
weighted imaging is of particular importance in the distinction of post-radiation necrosis 
from glioma recurrence. Especially, when PWI is employed in association with 1HMRS, the 
sensitivity and specificity of both methods increase significantly. When PWI shows a low 
Cerebral Blood Volume through the area of contrast enhancement, this usually suggests 
post-radiation necrosis, while high rCBV along with increased levels of Cho, and markedly 
increased Cho/Cr, Cho/NAA ratios are more suggestive of glioma recurrence. It has to be 
pointed out, however, that despite all these recent imaging advances, differentiation of post-
radiation necrosis from glioma recurrence may not be possible, and the employment of PET 
scan may be required in these cases.  
7. Conclusions 
The presence of ring enhancing lesions on brain MRI studies constitutes a frequent and quite 
challenging diagnostic dilemma. The differential diagnosis of lesions presenting as ring 
enhancing is quite extensive, and varies significantly with patient’s age and the 
geographical region. Unfortunately, clinical history and symptomatology along with 
conventional MRI cannot accurately differentiate and establish a diagnosis of these lesions. 
Proton MRS may contribute in their differential diagnosis and may enhance, alone or in 
combination with other advanced MR Imaging modalities, the specificity and the diagnostic 
accuracy of conventional MRI. Proton MRS is a non invasive MR based diagnostic modality, 
which provides a direct spectroscopic signature of the examined brain parenchymal area 
and its underlying pathology, and an indirect evaluation of the lesion’s metabolism. 
Detection of certain brain metabolites and calculation of their absolute and relative 
concentrations, are utilized in spectroscopic analysis. N-acetyl-aspartate,  Cho, Cr, Lac, 
Lipids, MI, cytosolic aminoacids, and metabolic ratios of NAA/Cho, NAA/Cr, and Cho/Cr 
are the most commonly calculated metabolites. Changes in their concentrations may 
contribute in the differential diagnosis of ring enhancing lesions, since specific spectroscopic 
profiles exist for most of these lesions. High grade gliomas, metastatic tumors, abscesses, 
evolving infarcts, and demyelinating lesions demonstrate a specific and characteristic 
spectrum. In addition, employment of DWI and PWI, may further increase the diagnostic 
accuracy of 1HMRS and conventional MRI in all these cases. Differentiation of post-radiation 
necrosis from tumor recurrence remains puzzling, despite all these advanced MR modalities 
and may require the employment of other imaging methodologies, such as PET. It has to be 
emphasized that 1HMRS carries significant technical limitations, and requires an 
experienced spectroscopist and neuroradiologist in order to avoid misinterpretation of the 
obtained data, and subsequently misdiagnosis of the studied lesion.  
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